130 related articles for article (PubMed ID: 36688864)
1. Genetic association in
Bellah SF; Salam MA; Billah SMS; Karim MR
Ann Hum Biol; 2023 Feb; 50(1):63-74. PubMed ID: 36688864
[TBL] [Abstract][Full Text] [Related]
2. Association of CYP3A4, CYP3A5 polymorphisms with lung cancer risk in Bangladeshi population.
Islam MS; Mostofa AG; Ahmed MU; Bin Sayeed MS; Hassan MR; Hasnat A
Tumour Biol; 2014 Feb; 35(2):1671-8. PubMed ID: 24085358
[TBL] [Abstract][Full Text] [Related]
3. CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancer.
Plummer SJ; Conti DV; Paris PL; Curran AP; Casey G; Witte JS
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):928-32. PubMed ID: 14504207
[TBL] [Abstract][Full Text] [Related]
4. The CYP3A4*1B allele increases risk for small cell lung cancer: effect of gender and smoking dose.
Dally H; Edler L; Jäger B; Schmezer P; Spiegelhalder B; Dienemann H; Drings P; Schulz V; Kayser K; Bartsch H; Risch A
Pharmacogenetics; 2003 Oct; 13(10):607-18. PubMed ID: 14515059
[TBL] [Abstract][Full Text] [Related]
5. The CYP3A4 *1B polymorphism and prostate cancer susceptibility in a Portuguese population.
Nogal A; Coelho A; Catarino R; Morais A; Lobo F; Medeiros R
Cancer Genet Cytogenet; 2007 Sep; 177(2):149-52. PubMed ID: 17854673
[TBL] [Abstract][Full Text] [Related]
6. Analysis of CYP3A4*1B and CYP3A5*3 polymorphisms in population of Bosnia and Herzegovina.
Semiz S; Dujić T; Ostanek B; Prnjavorac B; Bego T; Malenica M; Mlinar B; Marc J; Causević A
Med Glas (Zenica); 2011 Feb; 8(1):84-9. PubMed ID: 21263403
[TBL] [Abstract][Full Text] [Related]
7. Association between the CYP3A4 and CYP3A5 polymorphisms and cancer risk: a meta-analysis and meta-regression.
He XF; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Wei W
Tumour Biol; 2014 Oct; 35(10):9859-77. PubMed ID: 24989928
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans?
Kudzi W; Dodoo AN; Mills JJ
BMC Med Genet; 2010 Jul; 11():111. PubMed ID: 20630055
[TBL] [Abstract][Full Text] [Related]
9. Impact of CYP3A4*1B and CYP3A5*3 polymorphisms on the pharmacokinetics of cyclosporine and sirolimus in renal transplant recipients.
Żochowska D; Wyzgał J; Pączek L
Ann Transplant; 2012; 17(3):36-44. PubMed ID: 23018254
[TBL] [Abstract][Full Text] [Related]
10. Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.
Yousef AM; Bulatova NR; Newman W; Hakooz N; Ismail S; Qusa H; Zahran F; Anwar Ababneh N; Hasan F; Zaloom I; Khayat G; Al-Zmili R; Naffa R; Al-Diab O
Mol Biol Rep; 2012 Oct; 39(10):9423-33. PubMed ID: 22722998
[TBL] [Abstract][Full Text] [Related]
11. Influence of combined CYP3A4 and CYP3A5 single-nucleotide polymorphisms on tacrolimus exposure in kidney transplant recipients: a study according to the post-transplant phase.
Aouam K; Kolsi A; Kerkeni E; Ben Fredj N; Chaabane A; Monastiri K; Boughattas N
Pharmacogenomics; 2015 Dec; 16(18):2045-54. PubMed ID: 26615671
[TBL] [Abstract][Full Text] [Related]
12. Association of
Liang Y; Han W; Yan H; Mao Q
J Cancer Res Ther; 2018 Jun; 14(Supplement):S463-S467. PubMed ID: 29970707
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population.
Imtiaz H; Afroz S; Hossain MA; Bellah SF; Rahman MM; Kadir MS; Sultana R; Mazid MA; Rahman MM
Tumour Biol; 2019 Mar; 41(3):1010428319830837. PubMed ID: 30880589
[TBL] [Abstract][Full Text] [Related]
14. CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer.
Zeigler-Johnson C; Friebel T; Walker AH; Wang Y; Spangler E; Panossian S; Patacsil M; Aplenc R; Wein AJ; Malkowicz SB; Rebbeck TR
Cancer Res; 2004 Nov; 64(22):8461-7. PubMed ID: 15548719
[TBL] [Abstract][Full Text] [Related]
15. Association of CYP3A4/5 genotypes and expression with the survival of patients with neuroblastoma.
Darwish MH; Farah RA; Farhat GN; Torbey PH; Ghandour FA; Bejjani-Doueihy NA; Dhaini HR
Mol Med Rep; 2015 Feb; 11(2):1462-8. PubMed ID: 25370902
[TBL] [Abstract][Full Text] [Related]
16. CYP3A genotypes in Bangladeshi tuberculosis patients.
Maruf AA; Ahmed MU; Azad MA; Ahmed M; Hasnat A
Bangladesh Med Res Counc Bull; 2012 Apr; 38(1):1-5. PubMed ID: 22545342
[TBL] [Abstract][Full Text] [Related]
17. The rs776746 variant of CYP3A5 is associated with intravenous midazolam plasma levels and higher clearance in critically ill Mexican paediatric patients.
Flores-Pérez C; Castillejos-López MJ; Chávez-Pacheco JL; Dávila-Borja VM; Flores-Pérez J; Zárate-Castañón P; Acosta-Bastidas M; Cruz-Escobar J; Torres-Espíndola LM
J Clin Pharm Ther; 2021 Jun; 46(3):633-639. PubMed ID: 33638195
[TBL] [Abstract][Full Text] [Related]
18. Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients.
Gervasini G; García-Martín E; Ladero JM; Pizarro R; Sastre J; Martínez C; García M; Diaz-Rubio M; Agúndez JA
BMC Cancer; 2007 Jul; 7():118. PubMed ID: 17605821
[TBL] [Abstract][Full Text] [Related]
19. Association Between CYP3A4 and CYP3A5 Genotypes and Cyclosporine's Blood Levels and Doses among Jordanian Kidney Transplanted Patients.
El-Shair S; Al Shhab M; Zayed K; Alsmady M; Zihlif M
Curr Drug Metab; 2019; 20(8):682-694. PubMed ID: 31385766
[TBL] [Abstract][Full Text] [Related]
20. CYP3A5 3, CYP3A4 1B and MDR1 C3435T genotype distributions in Ecuadorians.
Sinués B; Vicente J; Fanlo A; Mayayo-Sinués E; González-Andrade F; Sánchez-Q D; Martínez-Jarreta B
Dis Markers; 2008; 24(6):325-31. PubMed ID: 18688081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]